GSK India announces 9% sales growth across General Medicines and Specialty business
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
New Board of Directors and management team at Suven Pharma also appointed
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated